Interferon-induced transmembrane protein 3 inhibits Hantaan virus infection, and its single nucleotide polymorphism rs12252 influences the severity of hemorrhagic fever with renal syndrome

Frontiers in Immunology

Volumn 7, Issue JAN, 2017, Pages

  Xu Yang, Zheng ^a   Pei Yu, Bian ^a   Chuan Tao, Ye ^a   Wei, Ye ^b   Hong Wei, Ma ^b   Kang, Tang ^b   Chun Mei, Zhang ^b   Ying Feng, Lei ^b   Xin, Wei ^a   Ping Zhong, Wang ^a   Chang Xing, Huang ^a   Xue Fan, Bai ^a   Ying, Zhang ^a   Zhan Sheng, Jia ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hantaan virus; Hemorrhagic fever with renal syndrome; Interferon induced transmembrane protein 3; Negative regulator of interferon response; Single nucleotide polymorphisms

Indexed keywords

ALPHA2A INTERFERON; INTERFERON INDUCED TRANSMEMBRANE PROTEIN; MEMBRANE PROTEIN; UNCLASSIFIED DRUG; VIRUS FUSION INHIBITOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CRUSH SYNDROME; DISEASE SEVERITY; FEMALE; GENE OVEREXPRESSION; HEMORRHAGIC FEVER; HEMORRHAGIC FEVER WITH RENAL SYNDROME; HUMAN; HUMAN CELL; MALE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNAI THERAPEUTICS; SINGLE NUCLEOTIDE POLYMORPHISM; VIRAL DISEASE IMMUNOFLUORESCENCE ASSAY; VIRUS ATTACHMENT; VIRUS LOAD; WESTERN BLOTTING;

EID: 85012050787     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00535     Document Type: Article

References (38)

1. Wang J, Guo W, Du H, Yu H, Jiang W, Zhu T, et al. Elevated soluble CD163 plasma levels are associated with disease severity in patients with hemorrhagic fever with renal syndrome. PLoS One (2014) 9(11):e112127. doi: 10.1371/journal.pone.0112127.
2. Yi J, Xu Z, Zhuang R, Wang J, Zhang Y, Ma Y, et al. Hantaan virus RNA load in patients having hemorrhagic fever with renal syndrome: correlation with disease severity. J Infect Dis (2013) 207(9):1457-61. doi:10.1093/infdis/jis475.
3. Lewin AR, Reid LE, McMahon M, Stark GR, Kerr IM. Molecular analysis of a human interferon-inducible gene family. Eur J Biochem (1991) 199(2):417-23. doi:10.1111/j.1432-1033.1991.tb16139.x.
4. Bailey CC, Zhong G, Huang IC, Farzan M. IFITM-family proteins: the cell's first line of antiviral defense. Annu Rev Virol (2014) 1:261-83. doi:10.1146/annurev-virology-031413-085537.
5. Diamond MS, Farzan M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat Rev Immunol (2013) 13(1):46-57. doi:10.1038/nri3344.
6. Bailey CC, Huang IC, Kam C, Farzan M. Ifitm3 limits the severity of acute influenza in mice. PLoS Pathog (2012) 8(9):e1002909. doi:10.1371/journal.ppat.1002909.
7. Brass AL, Huang IC, Benita Y, John SP, Krishnan MN, Feeley EM, et al. The IFITM proteins mediate cellular resistance to influenza A H1N1 virus, West Nile virus, and dengue virus. Cell (2009) 139(7):1243-54. doi:10.1016/j.cell.2009.12.017.
8. Zhu X, He Z, Yuan J, Wen W, Huang X, Hu Y, et al. IFITM3-containing exosome as a novel mediator for anti-viral response in dengue virus infection. Cell Microbiol (2015) 17(1):105-18. doi:10.1111/cmi.12339.
9. Wrensch F, Karsten CB, Gnirss K, Hoffmann M, Lu K, Takada A, et al. Interferon-induced transmembrane protein-mediated inhibition of host cell entry of ebolaviruses. J Infect Dis (2015) 212(Suppl 2):S210-8. doi:10.1093/infdis/jiv255.
10. Perreira JM, Chin CR, Feeley EM, Brass AL. IFITMs restrict the replication of multiple pathogenic viruses. J Mol Biol (2013) 425(24):4937-55. doi:10.1016/j.jmb.2013.09.024.
11. Huang IC, Bailey CC, Weyer JL, Radoshitzky SR, Becker MM, Chiang JJ, et al. Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog (2011) 7(1):e1001258. doi:10.1371/journal.ppat.1001258.
12. Amini-Bavil-Olyaee S, Choi YJ, Lee JH, Shi M, Huang IC, Farzan M, et al. The antiviral effector IFITM3 disrupts intracellular cholesterol homeostasis to block viral entry. Cell Host Microbe (2013) 13(4):452-64. doi:10.1016/j.chom.2013.03.006.
13. Zhang YH, Zhao Y, Li N, Peng YC, Giannoulatou E, Jin RH, et al. Interferon-induced transmembrane protein-3 genetic variant rs12252-C is associated with severe influenza in Chinese individuals. Nat Commun (2013) 4:1418. doi:10.1038/ncomms2433.
14. Ling S, Zhang C, Wang W, Cai X, Yu L, Wu F, et al. Combined approaches of EPR and NMR illustrate only one transmembrane helix in the human IFITM3. Sci Rep (2016) 6:24029. doi:10.1038/srep24029.
15. Everitt AR, Clare S, Pertel T, John SP, Wash RS, Smith SE, et al. IFITM3 restricts the morbidity and mortality associated with influenza. Nature (2012) 484(7395):519-23. doi:10.1038/nature10921.
16. Nam JH, Hwang KA, Yu CH, Kang TH, Shin JY, Choi WY, et al. Expression of interferon inducible genes following Hantaan virus infection as a mechanism of resistance in A549 cells. Virus Genes (2003) 26(1):31-8. doi:10.1023/A:1022373904357.
17. Geimonen E, NeffS, Raymond T, Kocer SS, Gavrilovskaya IN, Mackow ER. Pathogenic and nonpathogenic hantaviruses differentially regulate endothelial cell responses. Proc Natl Acad Sci U S A (2002) 99(21):13837-42. doi:10.1073/pnas.192298899.
18. Mudhasani R, Tran JP, Retterer C, Radoshitzky SR, Kota KP, Altamura LA, et al. IFITM-2 and IFITM-3 but not IFITM-1 restrict Rift Valley fever virus. J Virol (2013) 87(15):8451-64. doi:10.1128/JVI.03382-12.
19. Carpenter S. Long noncoding RNA: novel links between gene expression and innate immunity. Virus Res (2016) 212:137-45. doi:10.1016/j.virusres.2015.08.019.
20. Kambara H, Niazi F, Kostadinova L, Moonka DK, Siegel CT, Post AB, et al. Negative regulation of the interferon response by an interferon-induced long non-coding RNA. Nucleic Acids Res (2014) 42(16):10668-80. doi:10.1093/nar/gku713.
21. Ma Y, Liu B, Yuan B, Wang J, Yu H, Zhang Y, et al. Sustained high level of serum VEGF at convalescent stage contributes to the renal recovery after HTNV infection in patients with hemorrhagic fever with renal syndrome. Clin Dev Immunol (2012) 2012:812386. doi:10.1155/2012/812386.
22. Yu H, Jiang W, Du H, Xing Y, Bai G, Zhang Y, et al. Involvement of the Akt/NF-kappaB pathways in the HTNV-mediated increase of IL-6, CCL5, ICAM-1, and VCAM-1 in HUVECs. PLoS One (2014) 9(4):e93810. doi:10.1371/journal.pone.0093810.
23. Bhanja Chowdhury J, Shrivastava S, Steele R, Di Bisceglie AM, Ray R, Ray RB. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A. J Virol (2012) 86(18):10221-5. doi:10.1128/JVI.00882-12.
24. Zeisel A, Kostler WJ, Molotski N, Tsai JM, Krauthgamer R, Jacob-Hirsch J, et al. Coupled pre-mRNA and mRNA dynamics unveil operational strategies underlying transcriptional responses to stimuli. Mol Syst Biol (2011) 7:529. doi:10.1038/msb.2011.62.
25. Ouyang J, Zhu X, Chen Y, Wei H, Chen Q, Chi X, et al. NRAV, a long noncoding RNA, modulates antiviral responses through suppression of interferon-stimulated gene transcription. Cell Host Microbe (2014) 16(5):616-26. doi:10.1016/j.chom.2014.10.001.
26. Barriga GP, Villalon-Letelier F, Marquez CL, Bignon EA, Acuna R, Ross BH, et al. Inhibition of the hantavirus fusion process by predicted domain III and stem peptides from glycoprotein Gc. PLoS Negl Trop Dis (2016) 10(7):e0004799. doi:10.1371/journal.pntd.0004799.
27. Feeley EM, Sims JS, John SP, Chin CR, Pertel T, Chen LM, et al. IFITM3 inhibits influenza A virus infection by preventing cytosolic entry. PLoS Pathog (2011) 7(10):e1002337. doi:10.1371/journal.ppat.1002337.
28. Jin M, Park J, Lee S, Park B, Shin J, Song KJ, et al. Hantaan virus enters cells by clathrin-dependent receptor-mediated endocytosis. Virology (2002) 294(1):60-9. doi:10.1006/viro.2001.1303.
29. John SP, Chin CR, Perreira JM, Feeley EM, Aker AM, Savidis G, et al. The CD225 domain of IFITM3 is required for both IFITM protein association and inhibition of influenza A virus and dengue virus replication. J Virol (2013) 87(14):7837-52. doi:10.1128/JVI.00481-13.
30. Savidis G, Perreira JM, Portmann JM, Meraner P, Guo Z, Green S, et al. The IFITMs inhibit Zika virus replication. Cell Rep (2016) 15(11):2323-30. doi:10.1016/j.celrep.2016.05.074.
31. Raychoudhuri A, Shrivastava S, Steele R, Kim H, Ray R, Ray RB. ISG56 and IFITM1 proteins inhibit hepatitis C virus replication. J Virol (2011) 85(24):12881-9. doi:10.1128/JVI.05633-11.
32. Wilkins C, Woodward J, Lau DT, Barnes A, Joyce M, McFarlane N, et al. IFITM1 is a tight junction protein that inhibits hepatitis C virus entry. Hepatology (2013) 57(2):461-9. doi:10.1002/hep.26066.
33. Chutiwitoonchai N, Hiyoshi M, Hiyoshi-Yoshidomi Y, Hashimoto M, Tokunaga K, Suzu S. Characteristics of IFITM, the newly identified IFN-inducible anti-HIV-1 family proteins. Microbes Infect (2013) 15(4):280-90. doi:10.1016/j.micinf.2012.12.003.
34. Lu J, Pan Q, Rong L, He W, Liu SL, Liang C. The IFITM proteins inhibit HIV-1 infection. J Virol (2011) 85(5):2126-37. doi:10.1128/JVI.01531-10.
35. Smith S, Weston S, Kellam P, Marsh M. IFITM proteins-cellular inhibitors of viral entry. Curr Opin Virol (2014) 4:71-7. doi:10.1016/j.coviro.2013.11.004.
36. Li K, Markosyan RM, Zheng YM, Golfetto O, Bungart B, Li M, et al. IFITM proteins restrict viral membrane hemifusion. PLoS Pathog (2013) 9(1):e1003124. doi:10.1371/journal.ppat.1003124.
37. Gaio V, Nunes B, Pechirra P, Conde P, Guiomar R, Dias CM, et al. Hospitalization risk due to respiratory illness associated with genetic variation at IFITM3 in patients with influenza A(H1N1)pdm09 infection: a case-control study. PLoS One (2016) 11(6):e0158181. doi:10.1371/journal.pone.0158181.
38. Imamura K, Imamachi N, Akizuki G, Kumakura M, Kawaguchi A, Nagata K, et al. Long noncoding RNA NEAT1-dependent SFPQ relocation from promoter region to paraspeckle mediates IL8 expression upon immune stimuli. Mol Cell (2014) 53(3):393-406. doi:10.1016/j.molcel.2014.01.009.